Cross-Sectional Study Assessing the Feasibility of Using NET VITALS Communication Tool among Patients with Neuroendocrine Tumors
Introduction: Neuroendocrine tumor (NET) patients have reported ineffective communication with medical providers as a barrier to quality care.
Aim(s): To assess feasibility, patients’ perception of their understanding of their NET diagnosis, and patient satisfaction with using the NET VITALS questionnaire.
Materials and methods: NET VITALS, created by Los Angeles Carcinoid Neuroendocrine Tumor Society (LACNETS), is an 18 item communication tool consisting of domains from diagnosis to treatment. At the 2019 Annual LACNETS Conference, patients received NET VITALS and a satisfaction survey. The response rate, proportion of items completed, and satisfaction responses were used as indicators of feasibility, patients’ perception of their understanding of their NET diagnosis, and satisfaction with using NET VITALS respectively.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Li D
To read the full abstract, please log into your ENETS Member account.